SCHEMBL30865461

SCHEMBL30865461

CCn1nc(C(F)(F)F)cc1CN1CC2(C1)CN(C(=O)N1CC3(CC(n4cnc(C5(O)CC5)n4)C3)C1)C2

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 6/20 0.51
▸ GRIA2 P42262 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30865178 0.88 MGLL (0.53) MGLLGRIA2
SCHEMBL30865194 0.86 MGLL (0.68) MGLL
SCHEMBL30865365 0.84 MGLL (0.47) MGLL
SCHEMBL30865366 0.82 MGLL (0.43) MGLL
SCHEMBL30865388 0.82 MGLL (0.55) MGLL
SCHEMBL30865119 0.81 MGLL (0.75) MGLL
SCHEMBL30865140 0.81 MGLL (0.43) MGLL
SCHEMBL30865193 0.81 MGLL (0.59) MGLL
SCHEMBL30865129 0.80 MGLL (0.41) MGLL
SCHEMBL30865170 0.79 MGLL (0.44) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608823-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. Hoffmann-La Roche AG (CH) 2025-09-03 — — EP claimed
WO-2024088922-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. HOFFMANN-LA ROCHE AG (CH) 2024-05-02 — — WO claimed
EP-4608823-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. Hoffmann-La Roche AG (CH) 2025-09-03 — — EP disclosed
WO-2024088922-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. HOFFMANN-LA ROCHE AG (CH) 2024-05-02 — — WO disclosed
Send feedback